CLGN
CollPlant Biotechnologies Ltd
$0.37
+0.01 (+1.94%)
At close · Jul 8
Market Cap
$6.94M
Shares
18,908,207
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.37
Open$0.36
Day$0.35–0.38
52W$0.27–3.23
Avg vol 30d74K
Short int21K · 0.1% float · 1.0d
Short vol58%
Last earningsSep 30, 2024
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−69%
below
Price vs 50-day avg
−4%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
3%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−78%
trailing
YTD return
−74%
this year
Relative strength
−85%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
1 of 20 funds reported for Jun 30 · net -50 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.11% of float · ▼ -50.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
20 holders — near 3-yr high, broad support
Squeeze score
43
elevated · 0–100
Fundamentals
Revenue growth
+360%
Y/Y
Gross margin
65%
expanding
EPS growth
+35%
Y/Y
Free cash flow
$-9.4M
Balance sheet
$5.6M
net cash
Quant / Vol
risk profile
Volatility
115%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
13.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−69%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
3%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
1 of 20 funds reported for Jun 30 · net -50 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.11% of float · ▼ -50.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
20 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $0 · 3%
52-wk high $3
vs 200-day avg -69%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLGN
this stock
CollPlant Biotechnologies Ltd
|
$6.94M | -73.8% | +3565.2% | — | 0.1% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
20
- % held
- 8.1%
- Reported
- 1 of 20
- Top holder
- VILLERE ST DENIS J & CO L…
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLGN | +5.2% | -0.8% | -77.6% | +5.2% | -73.8% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +5.3% | -1.7% | -85.1% | +5.3% | -83.1% |